Armis Biopharma Announces 510(k) Clearance for VeriCyn® Wound Wash

FORT COLLINS, Colo., May 31, 2023 /PRNewswire/ — Armis Biopharma, Inc. announced today the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance for the VeriCyn® Wound Wash medical device. VeriCyn® Wound Wash provides skin-friendly wound care with a unique formula that is…

Click here to view original post